investors.amneal.comAmneal Pharmaceuticals, Inc. - Investor Relations
investors.amneal.com Profile
Investors.amneal.com is a subdomain of amneal.com, which was created on 2001-08-10,making it 23 years ago.
Discover investors.amneal.com website stats, rating, details and status online.Use our online tools to find owner and admin contact info. Find out where is server located.Read and write reviews or vote to improve it ranking. Check alliedvsaxis duplicates with related css, domain relations, most used words, social networks references. Go to regular site
investors.amneal.com Information
| HomePage size: 89.089 KB |
| Page Load Time: 0.811384 Seconds |
| Website IP Address: 162.159.130.11 |
investors.amneal.com Similar Website
| Masonite International Corp. - Investor Relations - Investor Relations |
| Block, Inc. (SQ) Investor Relations - Investor Relations |
| Gen Investor Relations - Investor Relations |
| MindChamps PreSchool Limited - Investor Relations: Investor Relations |
| Home - Ayala Land Investor Relations : Ayala Land Investor Relations |
| Universal Technical Institute's Investor Relations - UTI Investor Relations |
| Ameriprise Financial Investor Relations | Investor Relations |
| Meridian Bank Investor Relations - Meridian Bank Investor Relations |
| Armstrong World Industries Investor Relations | Armstrong Flooring Investor Relations |
| Walmart Investor Relations - Investor Relations |
| Alphabet Investor Relations - Investor Relations - Alphabet |
| Investor Relations | Jacobs - Investor Relations |
investors.amneal.com PopUrls
| Amneal Pharmaceuticals, Inc. - Investor Relations https://investors.amneal.com/investor-relations/ |
| Amneal Pharmaceuticals, Inc. - Investor Relations https://investors.amneal.com/investor-relations/default.aspx |
| Amneal Pharmaceuticals, Inc. - Stock Information https://investors.amneal.com/stock-information/default.aspx |
| Events & Presentations https://investors.amneal.com/events-and-presentations/default.aspx |
| Corporate Governance - Policies https://investors.amneal.com/corporate-governance/policies/default.aspx |
| News - Press Releases https://investors.amneal.com/news/press-releases/default.aspx |
| Investor Resources - Analysts https://investors.amneal.com/investor-resources/analysts/default.aspx |
| Financial Reports - SEC Filings https://investors.amneal.com/financial-reports/sec-filings/default.aspx |
| Investor Resources - Investor FAQ https://investors.amneal.com/investor-resources/investor-faq/default.aspx |
| Amneal Pharmaceuticals, Inc. - Financial Reports - Annual Reports https://investors.amneal.com/financial-reports/annual-reports/default.aspx |
| Amneal Reports Fourth Quarter and Full Year 2022 Financial Results https://investors.amneal.com/news/press-releases/press-release-details/2023/Amneal-Reports-Fourth-Quarter-and-Full-Year-2022-Financial-Results/default |
| Amneal Reports Fourth Quarter and Full Year 2023 Financial Results https://investors.amneal.com/news/press-releases/press-release-details/2024/Amneal-Reports-Fourth-Quarter-and-Full-Year-2023-Financial-Results/default |
| Amneal Reports Fourth Quarter and Full Year 2021 Financial Results https://investors.amneal.com/news/press-releases/press-release-details/2022/Amneal-Reports-Fourth-Quarter-and-Full-Year-2021-Financial-Results/default |
| Amneal Pharmaceuticals, Inc. - Amneal Reports Certain Preliminary First ... https://investors.amneal.com/news/press-releases/press-release-details/2023/Amneal-Reports-Certain-Preliminary-First-Quarter-2023-Financial-Results-an |
| Amneal Pharmaceuticals, Inc. - Amneal to Report Fourth Quarter and Full ... https://investors.amneal.com/news/press-releases/press-release-details/2022/Amneal-to-Report-Fourth-Quarter-and-Full-Year-2021-Results-on-March-2-2022 |
investors.amneal.com Httpheader
| Date: Tue, 14 May 2024 03:58:41 GMT |
| Content-Type: text/html; charset=utf-8 |
| Content-Length: 78117 |
| Connection: keep-alive |
| CF-Ray: 8837f89fba88cf8b-SJC |
| CF-Cache-Status: EXPIRED |
| Accept-Ranges: bytes |
| Cache-Control: public, max-age=10, stale-if-error=86400, stale-while-revalidate=86400 |
| ETag: 93ceaaf89bb139d004c93f4ac8a0dba9 |
| Strict-Transport-Security: max-age=31536000; includeSubDomains |
| Vary: Accept-Encoding |
| X-Content-Type-Options: nosniff |
| X-XSS-Protection: 0 |
| Server: cloudflare |
investors.amneal.com Meta Info
| content="text/html; charset=utf-8" http-equiv="Content-type"/ |
| content="RevealTrans(Duration=0,Transition=0)" http-equiv="Page-Enter"/ |
| content="IE=edge,chrome=1" http-equiv="X-UA-Compatible"/ |
| content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=0" name="viewport"/ |
| content="nlH0gWxOx5mh-bjuwoYCAfj3CRYWiaCrSgDgJc4ada8" name="google-site-verification"/ |
investors.amneal.com Html To Plain Text
Corporate Corporate (opens in a new tab) India (opens in a new tab) International Ask us anything: About About We challenge convention so healthy can be possible Our Story Amneal at-a-glance Our Founders Our Milestones Our Purpose & Commitments Our Culture Rise, Lead, Succeed Our Culture in ActionOur MilestonesOur Leadership Executive Leadership Board of Directors Our Locations Responsibility The Amneal Patient Assistance Programs Product Donations National & Local Philanthropy Compliance and Ethics Patient Community Connections Our Commitment to Parkinson’s Awards & RecognitionProducts Products We create essential medicines Our Portfolio Biosciences Generic Products Specialty Products Product Catalog Our Portfolio Generic Products U.S. Generics Catalog Learn About Generics Specialty ProductsQuality Drug Safety Adverse Event Reporting Medical Inquiries Product Complaints OperationsResearch & Development Research & Development We invest significantly in new product development Generics R&D Specialty R&D Drug Delivery Technologies Product PartneringInvestors Investors Become an Informed InvestorNews Careers Careers Help make healthy possible Total Rewards Search Our Career OpportunitiesContact Customer Login Investor Relations Financial Reports SEC Filings Annual Reports Quarterly & Other Reports Events & Presentations Stock Information Corporate Governance Policies Executive Officers & Directors Board Committees Investor Resources Analysts Investor FAQ Email Alerts Information Request RSS Feeds Home HomeInvestor Relations Amneal is a global, diversified pharmaceutical company that provides access to high-quality, affordable, and essential medicines. AMRX Corporate Fact SheetAMRX Corporate Fact SheetPress Releases Stock Information 6.71 AMRX (NASDAQ) + 0.05 + 0.75% Volume: 1,147,379 Pricing delayed 20 minutes 5/13/2024 04:00 PM In This Section Results & Reporting Review the latest results, trading conditions and financial reports. More Events & Presentations View upcoming events and latest presentations More Notice of Settlement Download year list Date Download May 18, 2023 Notice of Settlement (opens in new window) 250 KB May 11, 2023 Stipulation and Agreement of Compromise and Settlement (opens in new window) 170 KB Investor Faq Get answers to important investor relations questions. More Investor Tools Email Alerts RSS Feeds Email Page IR Contact Get answers to your investor relations questions. More Investor Faq Get answers to important investor relation questions. More Investor Tools Email Alerts RSS Feeds Email Page IR Contact Get answers to your investor relation questions. More Privacy Policy Copyright & Legal Disclaimer Web Accessibility © Amneal Pharmaceuticals LLC. All rights reserved. Powered By Q4 Inc. 5.122.0.3 (opens in new...
investors.amneal.com Whois
Domain Name: AMNEAL.COM Registry Domain ID: 75890482_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.networksolutions.com Registrar URL: http://networksolutions.com Updated Date: 2024-05-06T14:17:47Z Creation Date: 2001-08-10T03:24:52Z Registry Expiry Date: 2025-08-10T03:24:52Z Registrar: Network Solutions, LLC Registrar IANA ID: 2 Registrar Abuse Contact Email: domain.operations@web.com Registrar Abuse Contact Phone: +1.8777228662 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS-1382.AWSDNS-44.ORG Name Server: NS-145.AWSDNS-18.COM Name Server: NS-1745.AWSDNS-26.CO.UK Name Server: NS-805.AWSDNS-36.NET DNSSEC: unsigned >>> Last update of whois database: 2024-05-17T19:06:22Z <<<